NLM Logo

Immunotherapy, Adoptive MeSH Descriptor Data 2022


MeSH Heading
Immunotherapy, Adoptive
Tree Number(s)
E02.095.465.425.400.330.050.400
E05.478.550.520.050.400
Unique ID
D016219
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016219
Annotation
for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN
Scope Note
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Entry Version
IMMUNOTHER ADOPTIVE
Entry Term(s)
Adoptive Cellular Immunotherapy
Adoptive Immunotherapy
CAR T-Cell Therapy
Cellular Immunotherapy, Adoptive
Chimeric Antigen Receptor Therapy
Immunotherapy, Adoptive Cellular
NLM Classification #
QW 940
Previous Indexing
Immunization, Passive (1983-1990)
See Also
Receptors, Chimeric Antigen
History Note
1991
Date Established
1991/01/01
Date of Entry
1990/06/06
Revision Date
2018/07/02
Immunotherapy, Adoptive Preferred
Chimeric Antigen Receptor Therapy Narrower
page delivered in 0.176s